1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Live and Attenuated Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Live and Attenuated Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Live and Attenuated Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Live and Attenuated Vaccine Segment by Type
2.2.1 Pediatric Vaccine
2.2.2 Adult Vaccines
2.3 Live and Attenuated Vaccine Sales by Type
2.3.1 Global Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Live and Attenuated Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Live and Attenuated Vaccine Sale Price by Type (2018-2023)
2.4 Live and Attenuated Vaccine Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Diagnostic Centers
2.4.4 Research Institute
2.4.5 Others
2.5 Live and Attenuated Vaccine Sales by Application
2.5.1 Global Live and Attenuated Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Live and Attenuated Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Live and Attenuated Vaccine Sale Price by Application (2018-2023)
3 Global Live and Attenuated Vaccine by Company
3.1 Global Live and Attenuated Vaccine Breakdown Data by Company
3.1.1 Global Live and Attenuated Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Live and Attenuated Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Live and Attenuated Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Live and Attenuated Vaccine Revenue by Company (2018-2023)
3.2.2 Global Live and Attenuated Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Live and Attenuated Vaccine Sale Price by Company
3.4 Key Manufacturers Live and Attenuated Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live and Attenuated Vaccine Product Location Distribution
3.4.2 Players Live and Attenuated Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Live and Attenuated Vaccine by Geographic Region
4.1 World Historic Live and Attenuated Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Live and Attenuated Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Live and Attenuated Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Live and Attenuated Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Live and Attenuated Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Live and Attenuated Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Live and Attenuated Vaccine Sales Growth
4.4 APAC Live and Attenuated Vaccine Sales Growth
4.5 Europe Live and Attenuated Vaccine Sales Growth
4.6 Middle East & Africa Live and Attenuated Vaccine Sales Growth
5 Americas
5.1 Americas Live and Attenuated Vaccine Sales by Country
5.1.1 Americas Live and Attenuated Vaccine Sales by Country (2018-2023)
5.1.2 Americas Live and Attenuated Vaccine Revenue by Country (2018-2023)
5.2 Americas Live and Attenuated Vaccine Sales by Type
5.3 Americas Live and Attenuated Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live and Attenuated Vaccine Sales by Region
6.1.1 APAC Live and Attenuated Vaccine Sales by Region (2018-2023)
6.1.2 APAC Live and Attenuated Vaccine Revenue by Region (2018-2023)
6.2 APAC Live and Attenuated Vaccine Sales by Type
6.3 APAC Live and Attenuated Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Live and Attenuated Vaccine by Country
7.1.1 Europe Live and Attenuated Vaccine Sales by Country (2018-2023)
7.1.2 Europe Live and Attenuated Vaccine Revenue by Country (2018-2023)
7.2 Europe Live and Attenuated Vaccine Sales by Type
7.3 Europe Live and Attenuated Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Live and Attenuated Vaccine by Country
8.1.1 Middle East & Africa Live and Attenuated Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Live and Attenuated Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Live and Attenuated Vaccine Sales by Type
8.3 Middle East & Africa Live and Attenuated Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live and Attenuated Vaccine
10.3 Manufacturing Process Analysis of Live and Attenuated Vaccine
10.4 Industry Chain Structure of Live and Attenuated Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live and Attenuated Vaccine Distributors
11.3 Live and Attenuated Vaccine Customer
12 World Forecast Review for Live and Attenuated Vaccine by Geographic Region
12.1 Global Live and Attenuated Vaccine Market Size Forecast by Region
12.1.1 Global Live and Attenuated Vaccine Forecast by Region (2024-2029)
12.1.2 Global Live and Attenuated Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Live and Attenuated Vaccine Forecast by Type
12.7 Global Live and Attenuated Vaccine Forecast by Application
13 Key Players Analysis
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Live and Attenuated Vaccine Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 Merck & Co.
13.2.1 Merck & Co. Company Information
13.2.2 Merck & Co. Live and Attenuated Vaccine Product Portfolios and Specifications
13.2.3 Merck & Co. Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Main Business Overview
13.2.5 Merck & Co. Latest Developments
13.3 Pfizer, Inc
13.3.1 Pfizer, Inc Company Information
13.3.2 Pfizer, Inc Live and Attenuated Vaccine Product Portfolios and Specifications
13.3.3 Pfizer, Inc Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer, Inc Main Business Overview
13.3.5 Pfizer, Inc Latest Developments
13.4 Astellas Pharma Inc
13.4.1 Astellas Pharma Inc Company Information
13.4.2 Astellas Pharma Inc Live and Attenuated Vaccine Product Portfolios and Specifications
13.4.3 Astellas Pharma Inc Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Astellas Pharma Inc Main Business Overview
13.4.5 Astellas Pharma Inc Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Live and Attenuated Vaccine Product Portfolios and Specifications
13.5.3 Johnson & Johnson Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 CSL Limited
13.6.1 CSL Limited Company Information
13.6.2 CSL Limited Live and Attenuated Vaccine Product Portfolios and Specifications
13.6.3 CSL Limited Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSL Limited Main Business Overview
13.6.5 CSL Limited Latest Developments
13.7 Emergent BioSolutions, Inc.
13.7.1 Emergent BioSolutions, Inc. Company Information
13.7.2 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product Portfolios and Specifications
13.7.3 Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Emergent BioSolutions, Inc. Main Business Overview
13.7.5 Emergent BioSolutions, Inc. Latest Developments
13.8 MedImmune, LLC
13.8.1 MedImmune, LLC Company Information
13.8.2 MedImmune, LLC Live and Attenuated Vaccine Product Portfolios and Specifications
13.8.3 MedImmune, LLC Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 MedImmune, LLC Main Business Overview
13.8.5 MedImmune, LLC Latest Developments
13.9 Sanofi
13.9.1 Sanofi Company Information
13.9.2 Sanofi Live and Attenuated Vaccine Product Portfolios and Specifications
13.9.3 Sanofi Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sanofi Main Business Overview
13.9.5 Sanofi Latest Developments
13.10 Serum Institute
13.10.1 Serum Institute Company Information
13.10.2 Serum Institute Live and Attenuated Vaccine Product Portfolios and Specifications
13.10.3 Serum Institute Live and Attenuated Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Serum Institute Main Business Overview
13.10.5 Serum Institute Latest Developments
14 Research Findings and Conclusion
Table 1. Live and Attenuated Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Live and Attenuated Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Pediatric Vaccine
Table 4. Major Players of Adult Vaccines
Table 5. Global Live and Attenuated Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Live and Attenuated Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Live and Attenuated Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Live and Attenuated Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Live and Attenuated Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Live and Attenuated Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Live and Attenuated Vaccine Revenue by Application (2018-2023)
Table 13. Global Live and Attenuated Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Live and Attenuated Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Live and Attenuated Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Live and Attenuated Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Live and Attenuated Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Live and Attenuated Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Live and Attenuated Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Live and Attenuated Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live and Attenuated Vaccine Products Offered
Table 22. Live and Attenuated Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Live and Attenuated Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Live and Attenuated Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Live and Attenuated Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Live and Attenuated Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Live and Attenuated Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Live and Attenuated Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Live and Attenuated Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Live and Attenuated Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Live and Attenuated Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Live and Attenuated Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Live and Attenuated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Live and Attenuated Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Live and Attenuated Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Live and Attenuated Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Live and Attenuated Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Live and Attenuated Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Live and Attenuated Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Live and Attenuated Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Live and Attenuated Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Live and Attenuated Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Live and Attenuated Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Live and Attenuated Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Live and Attenuated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Live and Attenuated Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Live and Attenuated Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Live and Attenuated Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Live and Attenuated Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Live and Attenuated Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Live and Attenuated Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Live and Attenuated Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Live and Attenuated Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Live and Attenuated Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Live and Attenuated Vaccine
Table 58. Key Market Challenges & Risks of Live and Attenuated Vaccine
Table 59. Key Industry Trends of Live and Attenuated Vaccine
Table 60. Live and Attenuated Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Live and Attenuated Vaccine Distributors List
Table 63. Live and Attenuated Vaccine Customer List
Table 64. Global Live and Attenuated Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Live and Attenuated Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Live and Attenuated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Live and Attenuated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Live and Attenuated Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Live and Attenuated Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Live and Attenuated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Live and Attenuated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Live and Attenuated Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Live and Attenuated Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Live and Attenuated Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Live and Attenuated Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Live and Attenuated Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Live and Attenuated Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline Live and Attenuated Vaccine Product Portfolios and Specifications
Table 80. GlaxoSmithKline Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Merck & Co. Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. Live and Attenuated Vaccine Product Portfolios and Specifications
Table 85. Merck & Co. Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck & Co. Main Business
Table 87. Merck & Co. Latest Developments
Table 88. Pfizer, Inc Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer, Inc Live and Attenuated Vaccine Product Portfolios and Specifications
Table 90. Pfizer, Inc Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer, Inc Main Business
Table 92. Pfizer, Inc Latest Developments
Table 93. Astellas Pharma Inc Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Astellas Pharma Inc Live and Attenuated Vaccine Product Portfolios and Specifications
Table 95. Astellas Pharma Inc Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Astellas Pharma Inc Main Business
Table 97. Astellas Pharma Inc Latest Developments
Table 98. Johnson & Johnson Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Johnson & Johnson Live and Attenuated Vaccine Product Portfolios and Specifications
Table 100. Johnson & Johnson Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Johnson & Johnson Main Business
Table 102. Johnson & Johnson Latest Developments
Table 103. CSL Limited Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. CSL Limited Live and Attenuated Vaccine Product Portfolios and Specifications
Table 105. CSL Limited Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. CSL Limited Main Business
Table 107. CSL Limited Latest Developments
Table 108. Emergent BioSolutions, Inc. Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Product Portfolios and Specifications
Table 110. Emergent BioSolutions, Inc. Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Emergent BioSolutions, Inc. Main Business
Table 112. Emergent BioSolutions, Inc. Latest Developments
Table 113. MedImmune, LLC Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. MedImmune, LLC Live and Attenuated Vaccine Product Portfolios and Specifications
Table 115. MedImmune, LLC Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. MedImmune, LLC Main Business
Table 117. MedImmune, LLC Latest Developments
Table 118. Sanofi Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Sanofi Live and Attenuated Vaccine Product Portfolios and Specifications
Table 120. Sanofi Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Sanofi Main Business
Table 122. Sanofi Latest Developments
Table 123. Serum Institute Basic Information, Live and Attenuated Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. Serum Institute Live and Attenuated Vaccine Product Portfolios and Specifications
Table 125. Serum Institute Live and Attenuated Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Serum Institute Main Business
Table 127. Serum Institute Latest Developments
List of Figures
Figure 1. Picture of Live and Attenuated Vaccine
Figure 2. Live and Attenuated Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live and Attenuated Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Live and Attenuated Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Live and Attenuated Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Pediatric Vaccine
Figure 10. Product Picture of Adult Vaccines
Figure 11. Global Live and Attenuated Vaccine Sales Market Share by Type in 2022
Figure 12. Global Live and Attenuated Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Live and Attenuated Vaccine Consumed in Hospitals
Figure 14. Global Live and Attenuated Vaccine Market: Hospitals (2018-2023) & (K Units)
Figure 15. Live and Attenuated Vaccine Consumed in Clinics
Figure 16. Global Live and Attenuated Vaccine Market: Clinics (2018-2023) & (K Units)
Figure 17. Live and Attenuated Vaccine Consumed in Diagnostic Centers
Figure 18. Global Live and Attenuated Vaccine Market: Diagnostic Centers (2018-2023) & (K Units)
Figure 19. Live and Attenuated Vaccine Consumed in Research Institute
Figure 20. Global Live and Attenuated Vaccine Market: Research Institute (2018-2023) & (K Units)
Figure 21. Live and Attenuated Vaccine Consumed in Others
Figure 22. Global Live and Attenuated Vaccine Market: Others (2018-2023) & (K Units)
Figure 23. Global Live and Attenuated Vaccine Sales Market Share by Application (2022)
Figure 24. Global Live and Attenuated Vaccine Revenue Market Share by Application in 2022
Figure 25. Live and Attenuated Vaccine Sales Market by Company in 2022 (K Units)
Figure 26. Global Live and Attenuated Vaccine Sales Market Share by Company in 2022
Figure 27. Live and Attenuated Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Live and Attenuated Vaccine Revenue Market Share by Company in 2022
Figure 29. Global Live and Attenuated Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Live and Attenuated Vaccine Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Live and Attenuated Vaccine Sales 2018-2023 (K Units)
Figure 32. Americas Live and Attenuated Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. APAC Live and Attenuated Vaccine Sales 2018-2023 (K Units)
Figure 34. APAC Live and Attenuated Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Europe Live and Attenuated Vaccine Sales 2018-2023 (K Units)
Figure 36. Europe Live and Attenuated Vaccine Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Live and Attenuated Vaccine Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Live and Attenuated Vaccine Revenue 2018-2023 ($ Millions)
Figure 39. Americas Live and Attenuated Vaccine Sales Market Share by Country in 2022
Figure 40. Americas Live and Attenuated Vaccine Revenue Market Share by Country in 2022
Figure 41. Americas Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
Figure 42. Americas Live and Attenuated Vaccine Sales Market Share by Application (2018-2023)
Figure 43. United States Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Live and Attenuated Vaccine Sales Market Share by Region in 2022
Figure 48. APAC Live and Attenuated Vaccine Revenue Market Share by Regions in 2022
Figure 49. APAC Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
Figure 50. APAC Live and Attenuated Vaccine Sales Market Share by Application (2018-2023)
Figure 51. China Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Live and Attenuated Vaccine Sales Market Share by Country in 2022
Figure 59. Europe Live and Attenuated Vaccine Revenue Market Share by Country in 2022
Figure 60. Europe Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
Figure 61. Europe Live and Attenuated Vaccine Sales Market Share by Application (2018-2023)
Figure 62. Germany Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Live and Attenuated Vaccine Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Live and Attenuated Vaccine Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Live and Attenuated Vaccine Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Live and Attenuated Vaccine Sales Market Share by Application (2018-2023)
Figure 71. Egypt Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Live and Attenuated Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Live and Attenuated Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Live and Attenuated Vaccine
Figure 78. Industry Chain Structure of Live and Attenuated Vaccine
Figure 79. Channels of Distribution
Figure 80. Global Live and Attenuated Vaccine Sales Market Forecast by Region (2024-2029)
Figure 81. Global Live and Attenuated Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Live and Attenuated Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Live and Attenuated Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Live and Attenuated Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Live and Attenuated Vaccine Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
